Alliance Growers Corp - CSE: ACG
- Home
- Canada
- Vancouver, BC
- Alliance Growers Corp - CSE: ACG
Delivering clean, quality medicine in an environmentally sustainable manner The company was incorporated in 2014.
Address
1300/666 Burrard Street
Vancouver, BC
V6C3P6
Telephone
Website
Alerts
Be the first to know and let us send you an email when Alliance Growers Corp - CSE: ACG posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.
Contact The Practice
Send a message to Alliance Growers Corp - CSE: ACG:
Our Story
Alliance Growers Corp. (ACG:CSE) is a Diversified Global Medical Cannabis Company driven by the Company’s ‘Four Pillars’ Organization Plan – Cannabis Biotech Complex, Strategic ACMPR Investments, CBD Oil Supply and Distribution, and Research and Technology.
Alliance Growers is working with Pharmagreen Biotech Inc. advancing a new business partnership to jointly develop and operate a 62,000-square foot facility, to be the first of its kind in Western Canada to house a DNA Botany lab, Extraction Facility and Tissue Culture Plantlet Production Facility to service the Cannabis market and agriculture market in general. The proposed Cannabis Biotech Complex’s main facility is the Cannabis Biotech Centre, which will grow Cannabis plantlets using proprietary tissue culture propagation, specifically utilizing the “Chibafreen Invitro Plant Production System”, which allows for more tissue cultured plantlets to be produced in less space and less time.
Additionally, Alliance Growers has received all local permits for construction to commence at BiocannaTech, the Company’s wholly owned Quebec facility undertaking an Access to Cannabis for Medical Purposes Regulations (“ACMPR”) application in Montreal, Quebec. The Company’s two buildings are the only two locations in the Town of Mount Royal that are permitted for ma*****na production. A moratorium on such further development within TMR has been recently implemented.
Alliance Grower has secured access to a proprietary CBD h**p strain named “CBD DANA,”. The unique strain has been tested for a content of at least 10% CBD and less than 0.3% THC. This CBD yield is substantially greater than traditional h**p strains which typically have at most a 1% content. The lower THC content allows the strain to be classified as “industrial h**p” which makes it ideal for cultivation with less restrictive regulation.